Most Read Articles
Elaine Soliven, 27 Dec 2018
A lifestyle intervention programme focusing on healthy habits was associated with weight loss and better disease-free survival (DFS) among early breast cancer survivors, according to the SUCCESS C* study presented at SABCS 2018.
23 Dec 2018
TX-001HR, a fixed-dose combination of oestradiol and progesterone, yields clinically meaningful improvements in the frequency and/or severity vasomotor symptoms in menopausal women with a uterus, according to a study.
22 Dec 2018
Breastfeeding for more than 6 months after birth appears to be independently associated with a long-term decrease in waist circumference, reports a recent study.
Elaine Soliven, 11 Jul 2018

Adding bevacizumab to platinum-based chemotherapy significantly improves progression-free survival (PFS) in patients with recurrent ovarian cancer who were previously treated with first-line bevacizumab, according to the MITO16B - MaNGO OV2B - ENGOT OV17* study presented at ASCO 2018.

Oestrogen status modifies relationship between renal cell carcinoma risk and obesity in women

09 Sep 2018
The obesity epidemic hits Malaysia hard with cardiovascular disease occurring during younger ages.

Oestrogen status appears to be an important modifying factor for the interaction between obesity and renal cell carcinoma (RCC) risk in women, a recent study has shown. Specifically, high body mass index (BMI) is associated with elevated RCC risk in pre- but not postmenopausal women.

The study included 445 female RCC patients (mean age 53.4±12.1 years) and 508 age-matched cancer-free controls (mean age 52.3±12.5 years). Immunohistochemistry was used to determine the expression levels of oestrogen receptor-β and insulin-like growth factor-1 receptor in RCC tissues.

Setting a BMI cutoff of 25 kg/m2, researchers showed that RCC was significantly common in patients who were overweight than in those who were not (67.27 percent vs 77.60 percent; p=0.029). A similar trend was obtained for quartiles of waist circumference: there were more RCC patients than controls in the highest quartile (21.82 percent vs 11.45 percent; p=0.001).

Interestingly, these associations were observed only among premenopausal women. BMI (p=0.193) and waist circumference (p=0.072) showed no clear correlation with RCC frequency in postmenopausal participants.

This was confirmed in a multivariate logistic regression analysis, which showed that only premenopausal women who were overweight (odds ratio [OR], 1.67; 95 percent CI 1.01–2.76) and who were in the third (OR, 1.64; 1.12–2.39) or fourth (OR, 1.57; 1.07–2.30) quartiles of waist circumference were at significantly elevated risks of RCC.

No such associations were observed for the overall population (BMI 25 kg/m2: OR, 1.25; 0.95–1.65; quartile 3: OR, 1.64; 1.12–2.39; quartile 4: OR, 1.57; 1.07–2.30).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 27 Dec 2018
A lifestyle intervention programme focusing on healthy habits was associated with weight loss and better disease-free survival (DFS) among early breast cancer survivors, according to the SUCCESS C* study presented at SABCS 2018.
23 Dec 2018
TX-001HR, a fixed-dose combination of oestradiol and progesterone, yields clinically meaningful improvements in the frequency and/or severity vasomotor symptoms in menopausal women with a uterus, according to a study.
22 Dec 2018
Breastfeeding for more than 6 months after birth appears to be independently associated with a long-term decrease in waist circumference, reports a recent study.
Elaine Soliven, 11 Jul 2018

Adding bevacizumab to platinum-based chemotherapy significantly improves progression-free survival (PFS) in patients with recurrent ovarian cancer who were previously treated with first-line bevacizumab, according to the MITO16B - MaNGO OV2B - ENGOT OV17* study presented at ASCO 2018.